Xiamen Mengfali Health Technology Co., Ltd. announced that it expects to receive CNY 121.9935 million in funding from Ogawa Smart Healthcare Technology Group Co., Ltd., Xiamen Zhihu Enterprise Management Partnership (Limited Partnership, Xiamen Zhihongren Enterprise Management Partnership (Limited Partnership) and other investors
September 08, 2020
Share
Xiamen Mengfali Health Technology Co., Ltd. announced that it will raise an equity of CNY 121,993,500 on September 9, 2020. The registered capital of company consist of CNY 73,194,800, and capital reserve of CNY 48,798,700 as part of the transaction. The transaction included participation from new investors Xiamen Zhihu Enterprise Management Partnership (Limited Partnership) for capital of CNY 73,199,000 for 15% stake, Xiamen Zhihongren Enterprise Management Partnership (Limited Partnership) for CNY 24,394,800 for 5 % stake, individual investors Zou Jianhan for CNY 14,639,800 for 3% stake , Li Wuling for CNY 9,759,900 for 2% stake, and returning investor Ogawa Smart Healthcare Technology Group Co., Ltd. for 100% stake post transaction. The transaction was approved by third meeting of the fifth board of directors. The company registered capital will increase from CNY 219,596,100 to CNY 292,790,900 post-transaction.
Xiamen Comfort Science & Technology Group Co., Ltd. is a China-based company, principally engaged in the research and development, manufacture and distribution of intelligent health products. The Company mainly provides health massage, health environment, home medical and other products. The Company's products include health, health care products, massage small appliances and massage room appliances. The Company distributes its products within domestic market and to overseas markets.
Xiamen Mengfali Health Technology Co., Ltd. announced that it expects to receive CNY 121.9935 million in funding from Ogawa Smart Healthcare Technology Group Co., Ltd., Xiamen Zhihu Enterprise Management Partnership (Limited Partnership, Xiamen Zhihongren Enterprise Management Partnership (Limited Partnership) and other investors